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The molecular epidemiology of HIV-1 in Italy is becoming increasingly complex, mainly
due to the spread of non-B subtypes and the emergence of new recombinant forms.
We previously characterized the outbreak of the first Italian circulating recombinant
form (CRF60_BC), occurring among young MSM living in Apulia between the years
2009 and 2011. Here we show a 5-year follow-up surveillance to trace the evolution
of CRF60_BC and to investigate its further spread in Italy. We collected additional
sequences and clinical data from patients harboring CRF60_BC, enrolled at the
Infectious Diseases Clinic of the University of Bari. In addition to the 24 previously
identified sequences, we retrieved 27 CRF60_BC sequences from patients residing
in Apulia, whose epidemiological and clinical features did not differ from those of the
initial outbreak, i.e., the Italian origin, young age at HIV diagnosis (median: 24 years;
range: 18–37), MSM risk factor (23/25, 92%) and recent infection (from 2008 to 2017).
Sequence analysis revealed a growing overall nucleotide diversity, with few nucleotide
changes that were fixed over time. Twenty-seven additional sequences were detected
across Italy, spanning multiple distant regions. Using a BLAST search, we also identified
a CRF60_BC sequence isolated in United Kingdom in 2013. Three patients harbored
a unique second generation recombinant form in which CRF60_BC was one of the
parental strains. Our data show that CRF60_BC gained epidemic importance, spreading
among young MSM in multiple Italian regions and increasing its population size in
few years, as the number of sequences identified so far has triplicated since our first
report. The observed further divergence of CRF60_BC is likely due to evolutionary
bottlenecks and host adaptation during transmission chains. Of note, we detected
three second-generation recombinants, further supporting a widespread circulation of
CRF60_BC and the increasing complexity of the HIV-1 epidemic in Italy.
Keywords: HIV-1 recombinant forms, HIV-1 molecular epidemiology, HIV-1 evolution, HIV-1 outbreak, second
generation recombinants
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INTRODUCTION
The human immunodeficiency virus (HIV-1) is a well-known
moving target. HIV-1 high variability and rapid adaptation
impose an additional challenge to its diagnosis, treatment, and
prevention (Hemelaar, 2013). However, HIV-1 evolutionary
potential can be harnessed to understand its complex dynamics,
both at cellular and population level. Thanks to viral diversity,
molecular epidemiology allows to track HIV-1 global and local
epidemics and provide insights on how to control their further
diffusion (Hemelaar, 2012).
The pandemic group M spread worldwide and differentiated
over time into nine distinct subtypes (A–D, F–H, J, and K)
and 8 sub-subtypes (A1–A6, F1, and F2) (Peeters et al., 2014).
In addition to HIV-1 error prone reverse transcriptase and
high replicative potential, recombination plays a key role in
its variability (Hu and Hughes, 2012). Due to recombination,
when two or more subtypes co-circulate among high risk
groups in the same geographical area, unique recombinant
forms (URFs) emerge and, if they are detected in at least
three epidemiologically unrelated patients, they gain the role
of circulating recombinant forms (CRFs) (Robertson et al.,
1995). The number of identified CRFs has grown dramatically;
currently, 98 CRFs have been characterized and their virological
and epidemiological data are available at the Los Alamos HIV
database1. The first CRFs have been found mainly in central
Africa and South America, where multiple subtypes co-circulate
at high prevalence (Thomson et al., 2002). In the past few years,
some of these recombinant progenies have caused outbreaks
(Monno et al., 2012; Gonzalez-Domenech et al., 2018) and in
some cases have shown an increased fitness (Rawson et al., 2018).
For example, the Cuban CRF19_cpx, has been associated with
a higher viral load, a more rapid progression to AIDS (Kouri
et al., 2015) and antiretroviral resistance mutations (Kouri et al.,
2014). HIV-1 M chimeric forms, URFs and CRFs altogether,
are estimated to represent at least 20% of infections globally,
with CRF01_AE and CRF02_AG being the most prevalent,
accounting for about 13% of all infections (Osmanov et al., 2002).
Despite their origin, some CRFs gained epidemiological relevance
in previously B subtype-restricted countries with lower HIV-1
prevalence. Within the last years, multiple new CRFs have been
identified in European countries such as Russia (Liitsola et al.,
1998; Lukashov et al., 1999; Baryshev et al., 2014), Portugal,
Spain (Delgado et al., 2002; Fernandez-Garcia et al., 2016), Italy
(Simonetti et al., 2014), United Kingdom (Foster et al., 2014),
Luxembourg (Struck et al., 2015), and France (Leoz et al., 2013;
Recordon-Pinson et al., 2018).
The molecular epidemiology of HIV-1 in Italy, previously
a B-restricted area, has become complex, as migratory waves
and travels favored the penetration of HIV-1 forms from
countries where non-B subtypes prevail (Lai et al., 2012, 2014a,b,
2016). A comprehensive study reported that non-B variants
increased dramatically since the beginning of the epidemic with
a prevalence of 15.8 and 29.7% of all HIV-1 diagnoses from
2006 to 2016 (Rossetti et al., 2018). After subtype B, the three
1https://www.hiv.lanl.gov/content/sequence/HIV/CRFs/CRFs.html
most abundant pure subtypes in Italy were F, A and C, and
CRFs represented almost 50% of non-B forms (Lai et al., 2010).
Monno et al. (2012) reported a sudden HIV-1 outbreak among
young men-who-have-sex-with-men (MSM) residing in Apulia,
a region of southern Italy. This outbreak was caused by an inter-
subtype recombinant, which was identified as the first Italian
CRF, named CRF60_BC, by a subsequent study (Simonetti et al.,
2014). This recombinant form is mostly composed of subtype C
with the exception of three fragments from a parental B subtype
which covered a part of the 5′ LTR (HXB2 positions 0–462), a
small region of RT pol gene (HXB2 positions 2,804–3,037) and
the last part of env gene. Nef gene and most of the 3′ LTR (HXB2
positions 8,662–9,548) were also subtype B. At the time of its
characterization, the outbreak involved 22 individuals residing
in Apulia and additional few patients from Emilia-Romagna,
Tuscany and Sicily, all diagnosed between 2009 and 2011.
Here, we present a follow up study in which we investigated
the further circulation and evolution of CRF60_BC. We
combined epidemiological data with phylogenetic analyses on
sequences retrieved in Apulia and those available from a nation-
wide database. We observed an increasing population size and
evolution of CRF60_BC, whose spread resulted also in novel
recombination events. Overall, the present study portrays an
increasingly complex and dynamic landscape of the HIV-1
Italian epidemic.
MATERIALS AND METHODS
Patients
We collected sequences and clinical data from patients, harboring
CRF60_BC, enrolled at the Infectious Diseases Clinic of the
University of Bari. We found additional sequences from the
national ARCA cohort. Putative CRF60_BC sequences were
searched among those assigned to subtype C or CRF31_BC in
pol gene, according to a preliminary subtyping based on BLAST.
As the CRF60_BC contains a small portion of B subtype in this
region, the BLAST search lead to a subtype misclassification.
Sequences were retrieved from the genotypic drug resistance
assay performed by the local Services at diagnosis or prior to the
start of therapy or at treatment failure. Only the first available
resistance genotype was considered for downstream analyses.
Genotypic resistance from plasma HIV-RNA was determined
by bulk Sanger sequencing using commercially available or
homebrew methods, depending on the contributing laboratory.
ARCA is an observational HIV cohort approved by the
Regional Ethical Committee of Tuscany (Comitato Etico Area
Vasta Toscana Sudest). The study was conducted in accordance
with the 1964 Declaration of Helsinki and the ethical standards
of the Italian Ministry of Health. The national ARCA database,
currently contained demographic and viroimmunological data of
40,654 patients enrolled at 90 Clinical Centers, and at list one
sequence before the start of antiretroviral therapy for all subjects.
All patients belonging to the ARCA database provided informed
consent to have their anonymized data stored on a central server
and used for research studies. For all patients, epidemiological
data (gender, risk category, country of origin, date of diagnosis,
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and age) were collected by physicians from medical records
and then included in the databases together with virological,
immunological, and treatment information through standard
procedures cleared by the Southeast Tuscany Ethics Committee.
When available, analyses were conducted on multiple HIV-1
regions: protease (PRO), reverse transcriptase (RT), integrase
(INT), gp120 and gp41. The estimated time from infection was
calculated by computing the fraction of ambiguous nucleotides
in the PRO-RT sequences for all patients, as previously reported
(Kouyos et al., 2011).
Alignment and Phylogenetic Analysis
BioEdit version 7.2.6.12 was used to manually align query
sequences with pure subtypes and CRF reference sequences.
The alignment of a comprehensive list of reference sequences
of different subtypes (A1, A2, B, C, D, F1, F2, G, H, J,
K) was retrieved from the Los Alamos HIV database3. In
particular, we included 47, 37, 36, and 37 reference sequences
for PRO/RT, INT, gp120, and gp41 fragments, respectively. The
evolutionary model that best fitted the data was selected using
the information criterion implemented in JmodelTest v2.1.7
(Posada, 2008). We then conducted phylogenetic analyses for
subtyping on more than 10,000 sequences from the national
ARCA cohort with maximum likelihood approach implemented
in MEGA v7.0 program to retrieve additional CRF60_BC
circulating in Italy.
The monophyletic nature of the sequences was evaluated
by means of the MrBayes program (Huelsenbeck and
Ronquist, 2001) using a general-time reversible (GTR)
or Hasegawa-Kishino-Yano (HKY) model of nucleotide
substitution, a proportion of invariant sites, and gamma
distributed rates among sites for PRO, RT, gp120 and gp41
regions, respectively. For INT region HKY plus a proportion of
invariant sites was used. The final alignment encompassed 1,259,
1,029, 514, and 858 nucleotides for PRO/RT, gp120, gp41, and
INT regions, respectively.
A Markov Chain Monte Carlo (MCMC) search was made
for 2 × 106 generations using tree sampling every 100th
generation and a highly conservative burn-in fraction of 50%
to obtain a better signal of convergence. The analysis was run
until reaching the average standard deviation < 0.01. Statistical
support for specific clades was obtained by calculating the
posterior probability of each monophyletic clade, and a posterior
consensus tree was generated after a 50% burn-in.
Pairwise distances were measured with MEGA v7.0 (Kumar
et al., 2016), as the p-distance of each taxa from the
CRF60_BC sequence harbored by the patient with the oldest
time of diagnosis (patient BAV275, year 2005), with variance
estimation performed using 1,000 bootstrap replicates. Spearman
test of correlation between genetic distance and time of
diagnosis was conducted with GraphPad Prism v7.0. Nucleotide
differences across CFR60_BC sequences from Apulia were
plotted with Highlighter (Keele et al., 2008)4, with sequences
2http://www.mbio.ncsu.edu/bioedit/bioedit.html
3www.hiv.lanl.gov
4http://www.hiv.lanl.gov/content/sequence/HIGHLIGHT/highlighter_top.html
sorted according to tree topology; ambiguous IUPAC codes were
excluded from the graph.
Similarity and bootscanning plots implemented in Simplot
software v3.5.25 were used to identify the subtypes involved
in the recombination and their breakpoints to reconstruct
recombination pattern. Maximum Likelihood phylogenetic trees
were constructed for individual segments identified within each
breakpoint with bootstrapping on 1,000 replicates using MEGA
v7.0 program. Recombination was also characterized by split
decomposition method and neighbor-net network generated
with SplitsTree program6. Final trees were visualized and
annotated with FigTree v1.4.07.
HIV BLAST tool8 was used to retrieve sequences showing high
similarity and the same BC mosaic pattern within the Los Alamos
HIV Sequence Database. The prediction of HIV-1 co-receptor
usage was performed using Geno2Pheno9.
Phylodynamic Analysis
Dated trees of the CRF60_BC portions (INT, gp120, and gp41)
not containing recombination breakpoints were estimated by
BEAST software v1.8.4 (Drummond and Rambaut, 2007) using
the previously selected models. For this purpose, only sequences
with known date of collection were used. Chains were run
for 10–30 million generations with sampling every 1,000–3,000
generations. The results were visualized in Tracer v1.5 and
uncertainty in the estimates was indicated by 95% highest
probability density (HPD) intervals. Convergence was assessed
based on the ESS (effective-sample size) value and only parameter
estimates with ESS > 300 were accepted. The maximum clade
credibility (MCC) tree was then selected from the posterior
tree distribution using TreeAnnotator v1.8.4 available in the
BEAST software package. Final trees were visualized and edited
with FigTree v1.4.0.
RESULTS
Evolution of the CRF60_BC Outbreak
in Apulia
We first investigated whether the CRF60_BC had spread further
locally, where the original outbreak occurred in 2009–2011.
In addition to the 24 sequences previously described (Monno
et al., 2012), we retrieved from local clinical centers, 27 new
CRF60_BC sequences from patients residing in Apulia. The
epidemiological and clinical features of the patients carrying this
variant did not differ from those of the initial outbreak (Table 1).
Similarly to the patients previously described, these individuals
were Italian (100%) with young age at HIV-1 diagnosis (median:
26 years; range: 18–53) and all but one were MSM (25/26,
96%). The majority of these patients had a recent diagnosis
in 2012–2017 and a CD4+ T-cell count at diagnosis above
5http://sray.med.som.jhmi.edu/SCRoftware/simplot/
6http://www.splitstree.org/
7http://tree.bio.ed.ac.uk/software/figtree/
8http://www.hiv.lanl.gov/content/sequence/BASIC_BLAST/basic_blast.html
9https://coreceptor.geno2pheno.org/
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TABLE 1 | Characteristics of patients harboring CRF60_BC.
Characteristics CRF60_BC
(Monno et al., 2012)
(n = 24)
CRF60_BC new
from Apulia
(n = 27)
CRF60_BC new
outside Apulia
(n = 27)
Region [%; (n)]
Apulia 100 (24) 100 (27) –
Emilia – – 22.2 (6)
Tuscany – – 22.2 (6)
Sicilia – – 3.7 (1)
Marche – – 3.7 (1)
Liguria – – 3.7 (1)
Lombardy – – 3.7 (1)
Lazio – – 29.6 (8)
Trentino – – 3.7 (1)
Piemonte – – 3.7 (1)
Umbria – – 3.7 (1)
Unknown – – 3.7 (1)
Gender [%; (n)]
Male 91.7 (22) 100 (27) 81.4 (22)
Unknown 8.3 (2) – 14.8 (4)
Age at diagnosis [years]
Median [IQR] (n) 25 [25–25](24) 26 [22.5–29](27) 25 [25–34.5](12)
Year of diagnosis
Median [IQR] (n) 2010 [2010–2011](24) 2013
[2012–2015](27)
2013.5
[2013–2014](11)
Country of origin [%; (n)]
Italy 100 (24) 100 (27) 59.2 (16)
Cote d’Avoire – – 3.7 (1)
United Kingdom – – 3.7 (1)
Unknown – – 33.3 (9)
Modality of transmission
Men-who-have-sex-with-men 83.3 (20) 92.6 (25) 40.7 (11)
Other 16.7 (4) 3.7 (1) 3.7 (1)
Unknown – 3.7 (1) 55.5 (15)
CD4 count∗[cell/µl]
Median [IQR] (n) 465.5
[393.3–659.5](24)
506
[420–672.5](27)
570 [467–637](13)
pVL at sequencing [copies/mL]
Median [IQR] (n) 7,700
[3,150–32,500](24)
8,000
[4,700–26,000](27)
24,197 [7,528–
56,582.5](12)
Time from seroconversion [%; (n)]
Seroconversion within 12 month 54.5 (6) 60 (6) 66.7 (2)
Chronic 45.5 (5) 40 (4) 33.3 (1)
Estimated age of infection∗∗[%; (n)]
<1 year 75 (18) 77.8 (21) 40.7 (11)
>1 year 25 (6) 22.2 (6) 59.3 (16)
∗At the time of sequencing; ∗∗As in Kouyos et al. (2011).
350 cells/µl in 23 out 27 cases (median: 506 cells/µl; range:
46–1,187). Three subjects (BAV718, BAV731, BAV851) had levels
of plasma HIV-RNA above 106 copies/ml, suggesting that they
were diagnosed before reaching a viral set point. These data
support that most of the patients carrying the CRF60_BC
variant were infected recently, during the last few years after the
initial outbreak. However, we identified three subjects, BAV275,
BAV334, BAV420, whose HIV-1 infection occurred before the
initial outbreak, as their diagnosis dated back to 2005, 2006,
and 2008, respectively (Simonetti et al., 2014). These patients
were recorded in the ARCA database after the characterization
of CRF60_BC. Last negative test was available for 10 subjects and
confirmed a seroconversion time within 12 months in six cases.
The analysis of the fraction of ambiguous nucleotides provided
strong evidence of a recent infection (<1 year) for 77.8% (n = 21)
of subjects. The Bayesian tree of patients from Apulia is shown
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FIGURE 1 | Evolution of CRF60_BC PRO-RT sequences from Apulia. (A) Bayesian tree of PRO-RT Apulian sequences obtained by MrBayes program. Names of
sequences include the year of sampling. The newly identified sequences are shown in red, while those previously described are shown in blue. Posterior
probabilities > 0.8 are shown at nodes. (B) Highlighter plot of nucleotide mismatches in the protease and RT regions; sequences are sorted based on the topology
of the tree in (A), with the top sequence used as the master. Arrows and boxes indicate non-synonymous changes occurring in known epitopes under cytotoxic T
lymphocyte (CTL) pressure. Symbols indicated the sequence clusters present in the tree. (C) Correlation plot of genetic pairwise distances of HIV-1
diagnosis over time.
in Figure 1A. Twelve out 27 (44.4%) recently identified strains
showed high similarity with the majority of previous described
sequences (15/24, 62.5%). We identified six significant clusters
supported by a posterior probability higher than 0.80. Two of
them corresponded to known partners or epidemiological links
(pp = 1, BA889-BA921, BAV563-BAV564). The largest cluster
(pp = 1) involved one of the sequences identified in 2011 and
eight newly detected strains (year of diagnosis ranging between
2012 and 2017). Another large cluster (pp = 0.83) included four
previously described CRF60_BC sequences and one sequence
identified in 2012. The remaining two clusters (pp = 1 and
pp = 0.98, respectively) involved two strains each; the first
included two new sequences (BA840 and BA753) and the second
a previously described strain (BA667) with a new one (BA765).
The emergence of new cases of HIV-1 infection due
to CRF60_BC could be explained both by an increase of
diagnoses after the initial outbreak (more effective sampling)
and actual onward dissemination. To further understand whether
CRF60_BC has been involved in ongoing transmission chains,
we looked at sequence diversity and accumulation of mutations
over time (Figures 1B,C). We observed the emergence of
non-synonymous mutations strongly associated with CD8+
T-cell immune pressure against epitopes in gag (HXB2 position
498) and pol (HXB2 positions 69, 72, 128, and 314) (Addo et al.,
2003; Allen et al., 2005). Some mutations were fixed over time,
like in the case of the large transmission cluster encompassing
sequences from 2011 to 2017, in which we observed reversion to
subtype B consensus of a known conserved pol epitope (HXB2 pol
314) associated with HLA-I responses (Addo et al., 2003; Apps
et al., 2013). In addition, when we estimated pairwise distances of
all sequences (n = 47) from the oldest isolate (2005), we detected
a growing overall diversity that strongly correlated with time
of HIV-1 diagnosis (r = 0.82, p < 0.0001), further supporting
ongoing evolution of CRF60_BC over time.
Diffusion of CRF60_BC Outside Apulia
To investigate the further diffusion of CRF60_BC, we conducted
subtyping analyses on the ARCA database retrieving 25
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FIGURE 2 | Phylogenetic tree of CRF60_BC PRO-RT sequences detected in and outside of Apulia. Bayesian tree of PRO-RT CRF60_BC obtained using MrBayes
program. Posterior probabilities > 0.8 are shown at nodes. Sequences in blue are from Apulia region, in red those retrieved from other Italian regions and two
sequences detected using BLAST search. The brackets highlight the significant sub-clades.
sequences belonging to CRF60_BC (data not shown). Figure 2
shows the Bayesian tree containing 78 sequences: the original
and the newly identified sequences from Apulia (total, n = 51),
sequences from different Italian regions obtained from the ARCA
database (n = 25) and two sequences detected using BLAST
search (GU969560 and MF109718).
Sequences assigned to CRF60_BC formed a highly supported
cluster (pp = 1). Twenty-five sequences were detected across
the Italian territory (Rome, Florence, Modena, Arezzo, Fermo,
Pavia, Genoa, Perugia, Trento, and Turin). Some sub clusters
were observed, containing 2 to 9 strains. Sequences from
Apulia segregated alone, except for four sequences. Two
strains (BA840 and BA753) grouped significantly (pp = 1)
with a sequence from Modena (MOV-MO-1890) while the
remaining two (BA889 and BA921) formed a sub cluster with
a strain from Perugia (SI-19344) and a sequence detected
from a patient in United Kingdom (MF109718). This latter
sequence, retrieved by BLAST, had no demographic information
apart from the sampling date (November 2013), preventing
us to rule out whether the patient acquired the infection
in his/her country of origin or abroad. All sequences from
Rome (n = 7), with the exception of RM9-03323, formed
a significant (pp = 0.82) sub cluster. Three sequences from
Tuscany (one from Siena: SI-12520 and two from Florence:
FIV-7490 and FIV-7502) significantly grouped (pp = 0.95) with
a sequence from central Italy (ANV-1610-229). A second strain
was found by BLAST, isolated in Sicily from an African man with
unknown risk factors.
The epidemiological characteristics of subjects carrying
CRF60_BC residing outside Apulia (Table 1) did not differ
substantially from those residing in Apulia. All but one patients
were males (22/23, 96%), with a median age of 25 years (range:
21–52), diagnosed from 2009 to 2014 and, for subjects with
known risk factors, predominantly MSM (13/14, 92.8%). The last
negative HIV-1 test, available only for three patients, suggested
a recent seroconversion (less than 12 months) in two cases.
However, the analysis of the fraction of ambiguous nucleotides
indicated that the majority of patients (59.3%, n = 16) had been
infected for more than 1 year.
Emergence of Second Generation
Recombinant Forms
Three patients harbored URFs in which CRF60_BC was one
of the parental strains, as indicated by the phylogenetic trees
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FIGURE 3 | Recombination sites of 2nd generation recombinants involving CRF60_BC. Bootscan analyses of the three unique recombinant forms (URF) in which
CRF60_BC was one of the parental strains. Bootscanning plot is performed with the Simplot program using a window between 200 and 350 bp and step size
between 10 and 20 bp. (A) Bootscan of TNV-0015 in the integrase portion. (B) Bootscan of BA712 in the GP120 portion. (C) Bootscan of SRV8810 in the PRO-RT
portion. (D) Bootscan of CRF60_BC in the PRO-RT portion.
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shown in Supplementary Figures S1, S2, S3A. Figure 3 shows
the bootscan analysis of these sequences and the CRF60_BC
bootscan of pol region. Protease and RT regions of two of these
sequences clustered significantly with CRF60_BC confirming the
recombinant BC pattern, but different recombination patterns
were detected in INT for strain TNV-0015 (Figure 3A) and
in gp120 for BA712, in which CRF60_BC is subtype C. The
bootscan analysis identified a CRF60/G mosaic pattern with
two breakpoints at positions 4,848 and 4,907 (as mapped to
HXB2 reference) with a 60 base-pair fragment of subtype
G in the middle of the integrase region. Recombination
analysis on BA712 identified a CRF60/B recombinant with one
breakpoint at position 6,710 (Figure 3B). This recombination
structure in gp120 resulted in a switch in co-receptor viral
tropism from CCR5 to CXCR4. The sequence SRV8810, showed
a B/CFR60 mosaicism in the PRO-RT region (Figure 3C)
with a portion belonging to B subtype at the 3′ end of
protease (position 2,489).
Supplementary Figures S1, S2, S3B,C show the maximum
likelihood trees for individual segments identified within
each breakpoint confirming the recombination pattern
for all recombinants. Despite the presence of TNV-0015
(Supplementary Figure S1C) and SRV8810 (Supplementary
Figure S3B) in subtype G and B clades respectively, these clusters
are not bootstrap supported due to the limited length of the
analyzed fragments.
Phylodynamic Analysis
Evolutionary population dynamics were estimated based on
the data sets of non-recombinant regions (gp120 and gp41)
of CRF60_BC sequences from Apulia with known data. The
INT portion was not evaluated due to the limited availability
of sequences. After testing different coalescent priors (constant
population size, exponential growth, logistic growth, and
Bayesian skyline plot), using both strict and relaxed molecular
clock models, the Bayes factor (BF) analysis showed that the
relaxed lognormal molecular clock fitted the data better than
the strict clock model (2lnBF = 114.5) and the Bayesian skyline
plot fitted the data better than the other models. The estimated
mean rate of evolution was 7 × 10−3 substitutions per site per
year (s/s/y) (95%HPD: 5.1 × 10−3–9.2 × 10−3) and 6.2 × 10−3
s/s/y (95%HPD: 3.4 × 10−3–9.3 × 10−3) for the gp120 and
gp41, respectively. The time of the most recent common ancestor
(tMRCA) corresponding to the root of the trees was estimated
to be 11.4 years before the latest sampling data for both regions
(95%HPD: 11–12.85 years), corresponding to mid 2004, very
close to the year of diagnosis of the oldest sequence in our data
set (BAV275, 2005).
The Bayesian Skyline plot (Supplementary Figure S4) shows
the changes in population size at different times from the
root of the tree to the time of the most recent samples (year
2016 and 2017). The estimated effective number of infections
exponentially grew from the middle of 2006 to 2011, when
the initial outbreak was identified; after this period, the curve
reached a plateau and remained relatively constant until the latest
calendar years.
DISCUSSION
Although the first CRFs have been found in Africa and mainly
Central Africa, inter-subtype recombination events have also
occurred in other continents, leading to the spread of new CRFs.
Several CRFs have been described in Europe, as different non-
B subtypes circulate together with the founder B clade and are
detected at increasing prevalence almost in all countries (Tebit and
Arts, 2011). Several European CRFs show a mosaic structure due
to multiple recombination events with different parental subtypes;
however, the B clade is the most frequent parental subtype. Indeed,
HIV-1 superinfection, which underlies the recombination events,
has been frequently reported in MSM due to the numerous risk
contacts (Redd et al., 2013). As the B variant had a founder
effect within intravenous drug users in some European countries
including Italy (Lukashov et al., 1996), some of these CRFs
(CRF03_AB and CRF14_BG) mostly segregate in this specific high
risk population (Hemelaar, 2013). Some recombinant forms (i.e.,
CRF05_DF and CRF47_BF) have generated limited epidemics
both in frequency and regional dispersion (Fernandez-Garcia
et al., 2010), while others (CRF03_AB and CRF14_BG) have had
a relevant impact on the HIV-1 epidemic, both in the countries
of first detection and neighboring countries (Liitsola et al., 1998;
Delgado et al., 2002).
We previously described a new CRF epidemic in a single
Italian region (Apulia) mainly involving young MSM seeking
sexual partners through on-line dating websites, who acquired
HIV-1 infection in 2009–2011 and were diagnosed soon after
seroconversion (Monno et al., 2012; Simonetti et al., 2014). The
subtype C regions included in CRF60_BC are highly similar
to the South American variant, suggesting that CRF60_BC
originated in South America where subtypes B and C largely
co-circulate and other BC inter-subtype recombinants have been
documented (Hemelaar, 2013). Alternatively, CRF60_BC might
have originated in Italy where, subtype C, mostly harbored
by recent immigrants and Italian individuals who traveled to
endemic regions, accounts for 13% of non-B variants (Lai
et al., 2010). Additionally, our group recently conducted a
phylogeographic analysis revealing that the occurrence of subtype
C in Italy is related to the South American variant, likely due to
transmission chains among MSM (Lai et al., 2014a). To follow-up
the epidemic potential of the originally described CRF60_BC, we
traced its spread through a large Italian database collecting HIV-1
sequences prospectively.
CRF60_BC was originally limited to the Apulia region but
then reached distant regions of Italy. Increased sequence diversity
after the initial outbreak suggests evolutionary bottlenecks along
the transmission chains and adaptation to the host immune
pressure. This observation is supported by the fact that some
mutations, predominantly non-synonymous mutations, were
fixed overtime and that the growing diversity among strains
significantly correlates with the time of HIV-1 diagnosis. In this
study, most CRF60_BC variants circulate among young MSM
who recently acquired HIV-1 infection during the 2005–2017
period. These characteristics did not differ from those reported
for patients described in the initial outbreak, indicating that
CRF60_BC circulation is actually closely linked to MSM. Due to
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the higher prevalence in this population and HIV-1 increasing
genetic diversity, the MSM population might become a new
recombination hotspot, as observed in previous studies in China
reporting several CRFs among MSM population (Han et al., 2013;
Wu et al., 2013; Zhang et al., 2014). Noteworthy, the number
of sequences identified so far is three fold higher compared to
our first report.
In addition, we detected three second-generation
recombinants which further support a widespread circulation
of CRF60_BC, all of which showed recombination in different
portions of the HIV-1 genome. In one case, the recombination
pattern involved subtype G, an uncommon subtype that is
present only at 6% of non-B subtype strains (Lai et al., 2010).
In another case, recombination in gp120 entailed the coreceptor
switch to CXCR4, despite the recent acquisition of HIV-1
infection in 2012 confirmed by CD4+ T-cell count and viral load
measure at diagnosis. By identifying new recombinant forms with
a BC pattern in MSM, we demonstrated that these individuals
are likely to represent a preferential group that may give rise to
HIV-1 recombinants.
The finding of a patient carrying CRF60_BC diagnosed in
2005 indicates that the circulation of this strain probably began
in the early 2000s. The phylodinamic analysis set the origin
of CRF60_BC in the mid 2004 (range: 2003–2005) suggesting
that this subject could be one of the first cases of CRF60_BC.
The exponential growth of infections sustained by CRF60_BC
was observed in 2006–2011 period when most patients were
identified, suggesting a rapid spread among young MSM with
recent infection through Italy.
This study has some limitations. First, information related to
studied patients was not always available or complete. Second,
the data set in the current study may not be representative
of the entire country and we may have missed a number of
recently infected individuals present in additional local networks.
Regarding the unique recombinants, additional studies involving
single genome amplification and full-length genome sequencing,
are required to extend the characterization of the recombination
patterns and to exclude the role of superinfection. Despite our
analysis might represent an underestimate, our data strongly
suggest that CRF60_BC gained epidemic importance, spreading
in multiple Italian regions and increasing its population size in
very few years (2007–2013), among young MSM.
This is valuable information for public health agencies
developing strategies to prevent the HIV-1 epidemic to spread
into a more complex epidemiological landscape. In addition, our
results further highlight the need for better prevention campaigns
in young MSM, who represent a population with a poor control
of HIV-1 transmission (Volz et al., 2018). Finally, future studies
should continue to focus on transmission clusters and pay special
attention to recombinant forms, as these variants not only reflect
the changing landscape of HIV-1 diversity, but can also unveil the
onset of new epidemic bursts.
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